Predicting Response in TIME and Space: Neoadjuvant Chemoimmunotherapy in Muscle-invasive Bladder Cancer

被引：0
|
作者：
Yolmo, Priyanka [1 ,2 ]
Siemens, D. Robert [1 ,2 ,3 ]
Koti, Madhuri [1 ,2 ,3 ]
机构：
[1] Queens Univ, Dept Biomed & Mol Sci, 99 Univ Ave, Kingston, ON K7L3N6, Canada
[2] Queens Univ, Canc Res Inst, Kingston, ON, Canada
[3] Queens Univ, Dept Urol, Kingston, ON, Canada
来源：
EUROPEAN UROLOGY | 2024年 / 85卷 / 03期
关键词：
D O I：
10.1016/j.eururo.2023.12.003
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：254 / 256
页数：3
相关论文
共 50 条
  • [21] Re: Pathological Response to Neoadjuvant Chemotherapy for Muscle-Invasive Micropapillary Bladder Cancer
    Wood, David P.
    [J]. JOURNAL OF UROLOGY, 2014, 191 (03): : 628 - 628
  • [22] Neoadjuvant Immunotherapy in Muscle-Invasive Bladder Cancer: Time to Change Clinical Practice?
    Zhang, Sheng
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (11) : 939 - +
  • [23] Re: Predicting the Pathologic Complete Response after Neoadjuvant Pembrolizumab in Muscle-Invasive Bladder Cancer Editorial Comment
    Chang, Sam S.
    [J]. JOURNAL OF UROLOGY, 2022, 207 (05): : 1154 - 1155
  • [24] Radiomics-based model for predicting pathological complete response to neoadjuvant chemotherapy in muscle-invasive bladder cancer
    Choi, S. J.
    Park, K. J.
    Heo, C.
    Park, B. W.
    Kim, M.
    Kim, J. K.
    [J]. CLINICAL RADIOLOGY, 2021, 76 (08) : 627.e13 - 627.e21
  • [25] Role of B7-H3 in predicting response to neoadjuvant chemotherapy in muscle-invasive bladder cancer
    Deol, Ekamjit S.
    Nabavizadeh, Reza
    Lavoie, Roxane R.
    Dumbrava, Mihai G.
    Horjeti, Edlira
    Thapa, Prabin
    Cheville, John C.
    Frank, Igor
    Lucien, Fabrice
    [J]. BJUI COMPASS, 2024,
  • [26] Molecular Subtyping in Muscle-Invasive Bladder Cancer on Predicting Survival and Response of Treatment
    Bejrananda, Tanan
    Saetang, Jirakrit
    Sangkhathat, Surasak
    [J]. BIOMEDICINES, 2023, 11 (01)
  • [27] Determinants of neoadjuvant chemotherapy use in muscle-invasive bladder cancer
    Carvalho, Filipe L. F.
    Zeymo, Alexander
    Egan, Jillian
    Kelly, Colleen H.
    Zheng, Chaoyi
    Lynch, John H.
    Hwang, Jonathan
    Stamatakis, Lambros
    Krasnow, Ross E.
    Kowalczyk, Keith J.
    [J]. INVESTIGATIVE AND CLINICAL UROLOGY, 2020, 61 (04) : 390 - 396
  • [28] Towards Personalized Neoadjuvant Therapy for Muscle-invasive Bladder Cancer
    Li, Roger
    Spiess, Philippe E.
    Gilbert, Scott M.
    Necchi, Andrea
    [J]. EUROPEAN UROLOGY, 2019, 76 (01) : 4 - 6
  • [29] Multicenter Assessment of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer
    Zargar, Homayoun
    Espiritu, Patrick N.
    Fairey, Adrian S.
    Mertens, Laura S.
    Dinney, Colin P.
    Mir, Maria C.
    Krabbe, Laura-Maria
    Cookson, Michael S.
    Jacobsen, Niels-Erik
    Gandhi, Nilay M.
    Griffin, Joshua
    Montgomery, Jeffrey S.
    Vasdev, Nikhil
    Yu, Evan Y.
    Youssef, David
    Xylinas, Evanguelos
    Campain, Nicholas J.
    Kassouf, Wassim
    Dall'Era, Marc A.
    Seah, Jo-An
    Ercole, Cesar E.
    Horenblas, Simon
    Sridhar, Srikala S.
    McGrath, John S.
    Aning, Jonathan
    Shariat, Shahrokh F.
    Wright, Jonathan L.
    Thorpe, Andrew C.
    Morgan, Todd M.
    Holzbeierlein, Jeff M.
    Bivalacqua, Trinity J.
    North, Scott
    Barocas, Daniel A.
    Lotan, Yair
    Garcia, Jorge A.
    Stephenson, Andrew J.
    Shah, Jay B.
    van Rhijn, Bas W.
    Daneshmand, Siamak
    Spiess, Philippe E.
    Black, Peter C.
    [J]. EUROPEAN UROLOGY, 2015, 67 (02) : 241 - 249
  • [30] Comparison of Neoadjuvant and Adjuvant Chemotherapy in Muscle-invasive Bladder Cancer
    Macleod, Liam C.
    Fam, Mina M.
    Yabes, Jonathan G.
    Hale, Nathan E.
    Turner, Robert M., II
    Lopa, Samia H.
    Gingrich, Jeffrey R.
    Borza, Tudor
    Skolarus, Ted A.
    Davies, Benjamin J.
    Jacobs, Bruce L.
    [J]. CLINICAL GENITOURINARY CANCER, 2020, 18 (03) : 201 - +
12345